一例ARDS合并多发伤患者长期应用流控通气:病例报告
本文报告一例30岁严重多发伤(含重型颅脑损伤与创伤后ARDS)患者,因脊柱、骨盆等严重损伤,常规机械通气无法达到正常氧合与二氧化碳水平,导致血流动力学不稳定及难治性颅内高压;在俯卧位通气和体外膜氧合均禁忌的情况下,以超说明书方式使用流控通气(FCV)作为挽救治疗。数小时内通气改善且分钟通气量更低,去甲肾上腺素需求减少、颅内压恢复正常,FCV持续使用96小时。
要点
- FCV在常规通气失败的ARDS多发伤患者中可作为挽救治疗尝试
- FCV数小时内改善通气且分钟通气量更低,并减少升压药需求
- 该病例FCV持续使用96小时,提示长期应用可行性
核心结论
- 本病例提示FCV可能作为ARDS合并多发伤患者的挽救性通气模式,值得未来研究评估其结局影响。
研究设计与样本
- 单例病例报告:30岁严重多发伤患者,含重型颅脑损伤与创伤后ARDS。
主要发现
- 常规机械通气未能达到正常氧合与正常二氧化碳水平,导致血流动力学不稳定和难治性颅内高压。
- 因俯卧位通气和体外膜氧合禁忌,FCV作为超说明书挽救治疗使用。
- 数小时内通气改善且分钟通气量更低,同时去甲肾上腺素需求减少、颅内压恢复正常。
- FCV持续使用96小时。
临床怎么用
- 在ARDS合并多发伤且常规通气失败、俯卧位与ECMO禁忌时,可考虑FCV作为挽救治疗。
局限性
- 为单例病例报告,不能推断FCV的疗效或安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Flow-controlled ventilation (FCV) is characterized by a bidirectional linearized gas flow translating into a constant flow. We report the prolonged use of FCV in a 30-year-old patient with major trauma, including severe traumatic brain injury and posttraumatic ARDS, because the patient sustained other severe injuries such as those to the spine and pelvis. Conventional mechanical ventilation failed to attain normoxia and normocapnia, leading to hemodynamic compromise and refractory intracranial hypertension. FCV was used as an off-label rescue therapy because prone positioning and extracorporeal membrane oxygenation were contraindicated. Within a few hours, ventilation improved despite lower minute volumes. This was paralleled by a reduction in norepinephrine requirements and normalization of intracranial pressure. FCV was continued for 96 hours. This case report underlines the potential benefits of FCV as a novel ventilation mode in patients with ARDS and justifies future studies evaluating the outcome effects of FCV in this complex population.
引用
- Erblich R, Puchner W, Noitz M, et al. Prolonged Flow-Controlled Ventilation in a Patient With ARDS and Multiple Trauma: A Case Report. Chest. 2025. PMID: 41381142. doi:10.1016/j.chest.2025.06.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。